|
⚲
|
| Keyboard |
| Sommadossi Jean-Pierre
✚
|
|
|---|---|
| CIK # | 0001296995 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001296995] | |
| 4 | [0001296995] | |
| SC 13G | [0001296995] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Sommadossi Jean-Pierre | Atea Pharmaceuticals Inc | [2021-02-10] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Sommadossi Jean-Pierre | |
| Atea Pharmaceuticals Inc | |
| ABG Acquisition Corp I | |
| Kezar Life Sciences Inc | |
| JPM Partners LLC |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Atea Pharmaceuticals Inc AVIR
Stock Option (Right to Buy) · derivative
|
2026-02-03 | Option exercise | 300,000 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2026-02-03 | Option exercise | 300,000 | $1.24 | 372,000 |
|
Atea Pharmaceuticals Inc AVIR
Restricted Stock Units · derivative
|
2026-01-31 | Option exercise | 173,466 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2026-01-31 | Option exercise | 272,983 | ||
|
Atea Pharmaceuticals Inc AVIR
Restricted Stock Units · derivative
|
2026-01-31 | Option exercise | 99,517 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2026-01-31 | Tax withheld | 106,093 | $4.24 | 449,834 |
|
Atea Pharmaceuticals Inc AVIR
Restricted Stock Units · derivative
|
2025-01-31 | Option exercise | 173,467 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2025-01-31 | Grant | 99,517 | ||
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2025-01-31 | Option exercise | 173,467 | ||
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2025-01-31 | Tax withheld | 88,601 | $3.06 | 271,119 |
|
Atea Pharmaceuticals Inc AVIR
Stock Option (Right to Buy) · derivative
|
2025-01-31 | Grant | 440,000 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Restricted Stock Units · derivative
|
2025-01-31 | Grant | 99,518 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2024-09-19 | Sell | 1,841 | $4.00 | 7,364 |
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2024-09-18 | Sell | 22,187 | $4.03 | 89,414 |
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2024-09-17 | Sell | 33,941 | $4.05 | 137,461 |
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2024-06-05 | Sell | 1,006 | $4.00 | 4,024 |
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2024-02-01 | Sell | 56,910 | $3.85 | 219,104 |
|
Atea Pharmaceuticals Inc AVIR
Stock Option (Right to Buy) · derivative
|
2024-01-31 | Grant | 448,000 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Restricted Stock Units · derivative
|
2024-01-31 | Option exercise | 173,467 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2024-01-31 | Option exercise | 173,467 | ||
| showing 20 of 34 most recent transactions | |||||